Showing results (11-20 of 716) with videos related to
Sort By:
Pageof 72
Genome Biology|March 31, 2026
Benchmarking single-cell tumor immune atlases and application for uncovering cell states related to immunotherapy responseJing Yang, Yu Shyr, Qi LiuBMC Genomics|June 24, 2015
Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesisJing Wang, Qi Liu, Yu ShyrJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Nonsteroidal anti-inflammatory drugs and lung cancer risk: a population-based case control studyRichard J Wall, Yu Shyr, Walter SmalleyBMC Medical Research Methodology|June 7, 2025
Power and sample size calculation for non-inferiority trials with treatment switching in intention-to-treat analysis comparing RMSTsAustin Shih, Chih-Yuan Hsu, Yu ShyrBioinformatics (Oxford, England)|September 4, 2024
A distribution-free and analytic method for power and sample size calculation in single-cell differential expressionChih-Yuan Hsu, Qi Liu, Yu ShyrJournal of the National Cancer Institute|May 16, 2002
Effects of intercellular adhesion molecule 1 (ICAM-1) null mutation on radiation-induced pulmonary fibrosis and respiratory insufficiency in miceDennis E Hallahan, Ling Geng, Yu ShyrThe American Journal of Dermatopathology|May 19, 2005
Monster cells in malignant melanomaAlan S Boyd, Huiyun Wu, Yu ShyrJournal of the American Academy of Dermatology|February 6, 2008
Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastasesAlan S Boyd, Bashar Shakhtour, Yu ShyrGenome Research|October 12, 2022
Scalable and model-free detection of spatial patterns and colocalizationQi Liu, Chih-Yuan Hsu, Yu ShyrBMC Medical Research Methodology|February 24, 2023
Power and sample sizes estimation in clinical trials with treatment switching in intention-to-treat analysis: a simulation studyLejun Deng, Chih-Yuan Hsu, Yu ShyrPageof 72